By Paul W. Flint, MD, Professor and Chair, Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University, Portland, Oregon ; Bruce H. Haughey, MD, FACS, Professor and Director, Division of Head and Neck Surgical Oncology, Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, MO; Valerie J. Lund, CBE, MS, FRCS, FRCSEd, Professor of Rhinology, University College, London; Honorary Consultant ENT Surgeon, Royal National Throat, Nose and Ear Hospital Trust, University College and Moorfields Eye Hospitals, London, UK ; John K. Niparko, MD, Tiber Alpert Chair, Otolaryngology-Head & Neck Surgery, Keck School of Medicine of USC, Los Angeles, California ; K. Thomas Robbins, MD, FACS , Director, SimmonsCooper Cancer Institute at SIU; Professor, Division of Otolaryngology Head & Neck Surgery, Southern Illinois University School of Medicine, Springfield, IL and J. Regan Thomas, MD, FACS, Francis L. Lederer Professor, Department Head, Department of Otolaryngology-Head and Neck Surgery, University of Illinois at Chicago Medical Center, Chicago, IL